| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/07/2008 | EP1917266A1 Preparation of diazapentalene derivatives via epoxydation of dihydropyrroles |
| 05/07/2008 | EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 05/07/2008 | EP1558600B1 Selected cgrp antagonists, method for production and use thereof as medicament |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | CN101175758A Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide |
| 05/07/2008 | CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 05/07/2008 | CN101175738A Apoptosis promoters |
| 05/07/2008 | CN101175570A Porphyrin-based electrode catalyst |
| 05/07/2008 | CN101172977A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 05/07/2008 | CN101172976A Insect disinfestation component imidazo-triazine compounds |
| 05/07/2008 | CN101172930A 2.4-dihalogen-6-(C2-C3-alkyl)-phenyl substituted tetramic acid derivatives |
| 05/07/2008 | CN101172104A Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 05/07/2008 | CN100386328C Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 05/07/2008 | CN100386326C 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
| 05/06/2008 | US7368564 Bridged macrocyclic module compositions |
| 05/06/2008 | US7368458 N-(1-Benzyl-2-oxo-6-phenyl-1,2,3,4-tetrahydro-1,8-naphthyridin-3-yl)benzenesulfonamide; antagonists; regulation of appetite; obesity; smoking cessation |
| 05/06/2008 | US7368457 Bridged N-arylsulfonylpiperidines as gamma-secretase inhibitors |
| 05/06/2008 | US7368455 2-(4-fluorophenyl)-3-[2-(2-methoxy-1-methylethylamino)pyrimidin-4-yl]-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-one; cytokines (interleukin-1, 6, 8 and Tumor Necrosis Factor- alpha) inhibitor; antiinflammatory and antiarthritic agents; osteoporosis, rheumatic diseases; antidiabetic |
| 05/06/2008 | US7368453 Quinazolinone compounds with reduced bioaccumulation |
| 05/06/2008 | US7368449 2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists |
| 05/06/2008 | US7368445 Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 05/06/2008 | US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 05/06/2008 | US7368100 Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2283446C Photoactivatable nitrogen-containing bases based on .alpha.-amino alkenes |
| 05/06/2008 | CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008051887A1 Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols |
| 05/02/2008 | WO2008051808A2 Bicyclic triazoles as protein kinase modulators |
| 05/02/2008 | WO2008051493A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 05/02/2008 | WO2008050207A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 05/02/2008 | WO2008049994A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 05/02/2008 | WO2007109154A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 05/02/2008 | CA2667453A1 Triazolo-pyridazine protein kinase modulators |
| 05/02/2008 | CA2667428A1 Bicyclic triazoles as protein kinase modulators |
| 05/02/2008 | CA2667267A1 Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols |
| 05/02/2008 | CA2666618A1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 05/02/2008 | CA2664115A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90 |
| 05/01/2008 | US20080103188 Novel bicyclic compounds as modulators of androgen receptor function |
| 05/01/2008 | US20080103161 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
| 05/01/2008 | US20080103151 Heterocyclic compounds and their uses as therapeutic agents |
| 05/01/2008 | US20080103149 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 05/01/2008 | US20080103132 Fused heterocyclic compounds |
| 05/01/2008 | US20080103130 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality |
| 05/01/2008 | US20080103128 Lactams substituted by cyclic succinates as inhibitors of abetta protein production |
| 05/01/2008 | US20080103125 4-{2-[5-(4,6-Dimethyl-pyrimidine-5-carbonyl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-ethyl}-4-phenyl-piperidine-1-carboxylic acid tert-butyl ester,chemokine receptor antagonist; human immunodeficiency virus (HIV) infection, AIDS or ARC, antiinflammatory agent, autoimmune diseases, graft v. host disease |
| 04/30/2008 | EP1915378A1 Viral polymerase inhibitors |
| 04/30/2008 | EP1915377A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 04/30/2008 | EP1915376A1 6-phenyl-pyrazolopyrimidine-7-ylamine fungicides |
| 04/30/2008 | EP1915371A2 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase |
| 04/30/2008 | EP1597259B1 Nitrogen-substituted hexahydropyrazino 1,2-a pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
| 04/30/2008 | CN100384848C Porphyrin compound and electronic photographic sensitive unit, photoengraving box and equipment using same |
| 04/30/2008 | CN100384847C Adenosine a2a receptor antagonists |
| 04/30/2008 | CN100384846C Fused azole-pyrimidine derivatives |
| 04/30/2008 | CN100384417C Pyranoindazoles and their use for the treatment of glaucoma |
| 04/29/2008 | US7365211 Heterocyclic GABAA subtype selective receptor modulators |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365194 Dimer of phenazine-1-carboxylic acid and to the process of preparation thereof |
| 04/29/2008 | US7365193 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365078 Triaza-cyclopenta[cd]indene derivatives |
| 04/29/2008 | US7365072 Inhibitors of p38 |
| 04/29/2008 | US7365071 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2287470C Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| 04/29/2008 | CA2218887C Piperazino derivatives as neurokinin antagonists |
| 04/24/2008 | WO2008048867A2 Bicyclic heteroaromatic compounds |
| 04/24/2008 | WO2008047952A2 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound |
| 04/24/2008 | WO2008047951A2 An alzheimer' s disease progression inhibitor containing heterocyclic compound |
| 04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
| 04/24/2008 | WO2008047821A1 Fused heterocyclic compound |
| 04/24/2008 | WO2008047210A2 Compounds derived from 1 -ethyl-4,5-diamino-pyrazole and their use for oxidative dyeing of keratin fibres |
| 04/24/2008 | WO2008046582A1 Substituted tetrahydropyrrolopyrazine compounds having affinity with the kcnq2/3 k+ channel and use thereof in medicaments |
| 04/24/2008 | WO2008046581A2 Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments |
| 04/24/2008 | WO2008046232A1 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation |
| 04/24/2008 | WO2008046129A1 Phthalocyanine dyes suitable for use in offset inks |
| 04/24/2008 | WO2008020456A3 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 04/24/2008 | WO2007109799A3 Polymorphs of eszopiclone malate |
| 04/24/2008 | US20080097098 4,5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol; |
| 04/24/2008 | US20080097094 cis-6-(3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane; for controlling synaptic transmission, neurotransmitter release; Alzheimer's disease, Parkinson's disease, attention deficit disorder, depression, nicotinic withdrawal syndrome, Tourette's syndrome, schizophrenia and pain |
| 04/24/2008 | US20080096947 Polyvinylpyrrolidone or cyclodextrin as a builder, and polysorbate as a wetting agent, are dissolved with imexon in an organic solvent, preferably dimethyl sulfoxide, and lyophylized; lyophilisates are dissolved in aqueous propylene glycol; improved storage stability |
| 04/24/2008 | US20080096913 peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance; 3-[5-Methoxy-1-(3-methoxy-benzyl)-1H-indol-3-yl]-propionic acid |
| 04/24/2008 | US20080096905 efficient method that can independently optimize the substituents at C2 and C4; ease of use in the making of a combinatorial array; 4,6-substituted-2-methylsulfanyl-pyrimidine-5-carboxaldehyde is claimed intermediate |
| 04/24/2008 | US20080096903 inhibitors of disease-related target, Heat Shock Protein 90 (HSP90); antiproliferative; 2-chloro-5'-sulfamoyladenosine analogs; derivatives of adenine and other purines; Sulfamic Acid 2-[6-amino-2-fluoro-8-(6-iodo-benzo[1,3]dioxol-5-ylmethyl)-purin-9-yl]-ethyl ester |
| 04/24/2008 | US20080096880 Use of imidazo[1,2,4]triazinones which are inhibitors of cGMP-metabolizing phosphodiesterases (PDE I, II and V) to treat cardiovascular disorders, urogenital disorders, prostate hyperplasia, ocular disorders such as glaucoma, optic neuropathy, diabetic gastroparesis, dementia |
| 04/24/2008 | US20080096873 New compounds |
| 04/24/2008 | US20080096868 [1-(4-methoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-o-tolyl-amine for example; protein tyrosine kinase inhibitors; anticancer agents |
| 04/24/2008 | US20080096862 Lactam compounds and pharmaceutical use thereof |
| 04/24/2008 | US20080095950 Compositions Containing Phthalocyanine Dyes |
| 04/24/2008 | US20080093301 For removal of air pollutants or water contaminants, and separation and purification of biological, organic, inorganic, or ionic substances; filters |
| 04/24/2008 | CA2702605A1 Unprotected amino aldehydes and applications for same |
| 04/24/2008 | CA2666664A1 Sulfamoyl-containing derivatives and uses thereof |
| 04/24/2008 | CA2666647A1 Substituted tetrahydropyrrolopyrazine compounds with affinity for the kcnq2/3 k+ channel and the use thereof in medicaments |
| 04/24/2008 | CA2666360A1 An alzheimer's disease progression inhibitor containing heterocyclic compound having specific structure |
| 04/24/2008 | CA2662727A1 Phthalocyanine dyes suitable for use in offset inks |
| 04/23/2008 | EP1913092A1 Red-shifted water-dispersible ir dyes |
| 04/23/2008 | EP1913000A2 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
| 04/23/2008 | EP1912999A1 Macrocyclic inhibitors of hepatitis c virus |
| 04/23/2008 | EP1912998A1 Pyrazole derivatives having tyrosinkinase activity |